Kupffer cell products and interleukin 1 beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes

Plasma VLDL accumulation in Gram-negative sepsis is partly ascribed to an increased hepatic VLDL production driven by pro-inflammatory cytokines. We previously showed that hepatocytes of the Kupffer cell (KC)-rich periportal area are major contributors to enhanced VLDL production in lipopolysacchari...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Innate immunity (London, England) England), 2008-08, Vol.14 (4), p.255-266
Hauptverfasser: Bartolome, N, Arteta, B, Martinez, MJ, Chico, Y, Ochoa, B
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 266
container_issue 4
container_start_page 255
container_title Innate immunity (London, England)
container_volume 14
creator Bartolome, N
Arteta, B
Martinez, MJ
Chico, Y
Ochoa, B
description Plasma VLDL accumulation in Gram-negative sepsis is partly ascribed to an increased hepatic VLDL production driven by pro-inflammatory cytokines. We previously showed that hepatocytes of the Kupffer cell (KC)-rich periportal area are major contributors to enhanced VLDL production in lipopolysaccharide (LPS)-injected rats. However, it remains to be established whether KC generated products directly affect the number (apoB) and composition of secreted VLDL. Using rat primary cells, we show here that hepatocytes respond to stimulation by soluble mediators released by LPS-stimulated Kupffer cells with enhanced secretion of apoB and triglycerides in phospholipid-rich VLDL particles. Unstimulated KC products also augmented the secretion of normal VLDL, doubling apoB mRNA abundance. IL-1 beta treatment resulted in concentration-dependent increases of hepatocyte apoB mRNA and protein secretion, increases that were greater, but not additive, when combined with IL-6 and TNF- alpha . Lipid secretion and MTP mRNA levels were unaffected by cytokines. In summary: (i) enhanced secretion of phospholipid-rich VLDL particles is a net hepatocyte response to LPS-stimulated KC products, which gives a clue about the local role of Kupffer cells in septic dyslipidemia induction; and (ii) pro-inflammatory cytokines act redundantly to enhance apoB secretion involving translational apoB up-regulation, but other humoral components or KC mediators are necessary to accomplish increased lipid association.
doi_str_mv 10.1177/1753425908094718
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_20210402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20210402</sourcerecordid><originalsourceid>FETCH-LOGICAL-p186t-e7013bf045eefdba0937cf774b775ff4966394ef98f8a7ca52922e5591b5fd053</originalsourceid><addsrcrecordid>eNotjz1PwzAQhj2ARCnsjJ7YAmfHjuOxFCiICCQErJXjnCGQL2J76MJvJylMr_Tc3aN7CTljcMGYUpdMyVRwqSEHLRTLD8hiRsnMjsix958AGQepFuTnIQ7O4UgtNg0dxr6KNnhquorWXcCxwfhVd5TREoOhVT2iDc1uXmz7gPStuC6oRztiqPtuf2aG_oq2z48rGodkxPfYmP1sskx27AL9wMGE3u4C-hNy6Ezj8fQ_l-T19uZlfZcUT5v79apIBpZnIUEFLC0dCInoqtKATpV1SolSKemc0FmWaoFO5y43yhrJNecopWaldBXIdEnO_7zT498Rfdi2tZ8rmw776LccOAMBPP0FvCNhqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20210402</pqid></control><display><type>article</type><title>Kupffer cell products and interleukin 1 beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes</title><source>Sage Journals GOLD Open Access 2024</source><source>Alma/SFX Local Collection</source><creator>Bartolome, N ; Arteta, B ; Martinez, MJ ; Chico, Y ; Ochoa, B</creator><creatorcontrib>Bartolome, N ; Arteta, B ; Martinez, MJ ; Chico, Y ; Ochoa, B</creatorcontrib><description>Plasma VLDL accumulation in Gram-negative sepsis is partly ascribed to an increased hepatic VLDL production driven by pro-inflammatory cytokines. We previously showed that hepatocytes of the Kupffer cell (KC)-rich periportal area are major contributors to enhanced VLDL production in lipopolysaccharide (LPS)-injected rats. However, it remains to be established whether KC generated products directly affect the number (apoB) and composition of secreted VLDL. Using rat primary cells, we show here that hepatocytes respond to stimulation by soluble mediators released by LPS-stimulated Kupffer cells with enhanced secretion of apoB and triglycerides in phospholipid-rich VLDL particles. Unstimulated KC products also augmented the secretion of normal VLDL, doubling apoB mRNA abundance. IL-1 beta treatment resulted in concentration-dependent increases of hepatocyte apoB mRNA and protein secretion, increases that were greater, but not additive, when combined with IL-6 and TNF- alpha . Lipid secretion and MTP mRNA levels were unaffected by cytokines. In summary: (i) enhanced secretion of phospholipid-rich VLDL particles is a net hepatocyte response to LPS-stimulated KC products, which gives a clue about the local role of Kupffer cells in septic dyslipidemia induction; and (ii) pro-inflammatory cytokines act redundantly to enhance apoB secretion involving translational apoB up-regulation, but other humoral components or KC mediators are necessary to accomplish increased lipid association.</description><identifier>ISSN: 1753-4259</identifier><identifier>DOI: 10.1177/1753425908094718</identifier><language>eng</language><ispartof>Innate immunity (London, England), 2008-08, Vol.14 (4), p.255-266</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bartolome, N</creatorcontrib><creatorcontrib>Arteta, B</creatorcontrib><creatorcontrib>Martinez, MJ</creatorcontrib><creatorcontrib>Chico, Y</creatorcontrib><creatorcontrib>Ochoa, B</creatorcontrib><title>Kupffer cell products and interleukin 1 beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes</title><title>Innate immunity (London, England)</title><description>Plasma VLDL accumulation in Gram-negative sepsis is partly ascribed to an increased hepatic VLDL production driven by pro-inflammatory cytokines. We previously showed that hepatocytes of the Kupffer cell (KC)-rich periportal area are major contributors to enhanced VLDL production in lipopolysaccharide (LPS)-injected rats. However, it remains to be established whether KC generated products directly affect the number (apoB) and composition of secreted VLDL. Using rat primary cells, we show here that hepatocytes respond to stimulation by soluble mediators released by LPS-stimulated Kupffer cells with enhanced secretion of apoB and triglycerides in phospholipid-rich VLDL particles. Unstimulated KC products also augmented the secretion of normal VLDL, doubling apoB mRNA abundance. IL-1 beta treatment resulted in concentration-dependent increases of hepatocyte apoB mRNA and protein secretion, increases that were greater, but not additive, when combined with IL-6 and TNF- alpha . Lipid secretion and MTP mRNA levels were unaffected by cytokines. In summary: (i) enhanced secretion of phospholipid-rich VLDL particles is a net hepatocyte response to LPS-stimulated KC products, which gives a clue about the local role of Kupffer cells in septic dyslipidemia induction; and (ii) pro-inflammatory cytokines act redundantly to enhance apoB secretion involving translational apoB up-regulation, but other humoral components or KC mediators are necessary to accomplish increased lipid association.</description><issn>1753-4259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNotjz1PwzAQhj2ARCnsjJ7YAmfHjuOxFCiICCQErJXjnCGQL2J76MJvJylMr_Tc3aN7CTljcMGYUpdMyVRwqSEHLRTLD8hiRsnMjsix958AGQepFuTnIQ7O4UgtNg0dxr6KNnhquorWXcCxwfhVd5TREoOhVT2iDc1uXmz7gPStuC6oRztiqPtuf2aG_oq2z48rGodkxPfYmP1sskx27AL9wMGE3u4C-hNy6Ezj8fQ_l-T19uZlfZcUT5v79apIBpZnIUEFLC0dCInoqtKATpV1SolSKemc0FmWaoFO5y43yhrJNecopWaldBXIdEnO_7zT498Rfdi2tZ8rmw776LccOAMBPP0FvCNhqg</recordid><startdate>20080801</startdate><enddate>20080801</enddate><creator>Bartolome, N</creator><creator>Arteta, B</creator><creator>Martinez, MJ</creator><creator>Chico, Y</creator><creator>Ochoa, B</creator><scope>7QL</scope><scope>7T5</scope><scope>7TM</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20080801</creationdate><title>Kupffer cell products and interleukin 1 beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes</title><author>Bartolome, N ; Arteta, B ; Martinez, MJ ; Chico, Y ; Ochoa, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p186t-e7013bf045eefdba0937cf774b775ff4966394ef98f8a7ca52922e5591b5fd053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bartolome, N</creatorcontrib><creatorcontrib>Arteta, B</creatorcontrib><creatorcontrib>Martinez, MJ</creatorcontrib><creatorcontrib>Chico, Y</creatorcontrib><creatorcontrib>Ochoa, B</creatorcontrib><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Innate immunity (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bartolome, N</au><au>Arteta, B</au><au>Martinez, MJ</au><au>Chico, Y</au><au>Ochoa, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kupffer cell products and interleukin 1 beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes</atitle><jtitle>Innate immunity (London, England)</jtitle><date>2008-08-01</date><risdate>2008</risdate><volume>14</volume><issue>4</issue><spage>255</spage><epage>266</epage><pages>255-266</pages><issn>1753-4259</issn><abstract>Plasma VLDL accumulation in Gram-negative sepsis is partly ascribed to an increased hepatic VLDL production driven by pro-inflammatory cytokines. We previously showed that hepatocytes of the Kupffer cell (KC)-rich periportal area are major contributors to enhanced VLDL production in lipopolysaccharide (LPS)-injected rats. However, it remains to be established whether KC generated products directly affect the number (apoB) and composition of secreted VLDL. Using rat primary cells, we show here that hepatocytes respond to stimulation by soluble mediators released by LPS-stimulated Kupffer cells with enhanced secretion of apoB and triglycerides in phospholipid-rich VLDL particles. Unstimulated KC products also augmented the secretion of normal VLDL, doubling apoB mRNA abundance. IL-1 beta treatment resulted in concentration-dependent increases of hepatocyte apoB mRNA and protein secretion, increases that were greater, but not additive, when combined with IL-6 and TNF- alpha . Lipid secretion and MTP mRNA levels were unaffected by cytokines. In summary: (i) enhanced secretion of phospholipid-rich VLDL particles is a net hepatocyte response to LPS-stimulated KC products, which gives a clue about the local role of Kupffer cells in septic dyslipidemia induction; and (ii) pro-inflammatory cytokines act redundantly to enhance apoB secretion involving translational apoB up-regulation, but other humoral components or KC mediators are necessary to accomplish increased lipid association.</abstract><doi>10.1177/1753425908094718</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1753-4259
ispartof Innate immunity (London, England), 2008-08, Vol.14 (4), p.255-266
issn 1753-4259
language eng
recordid cdi_proquest_miscellaneous_20210402
source Sage Journals GOLD Open Access 2024; Alma/SFX Local Collection
title Kupffer cell products and interleukin 1 beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A12%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kupffer%20cell%20products%20and%20interleukin%201%20beta%20directly%20promote%20VLDL%20secretion%20and%20apoB%20mRNA%20up-regulation%20in%20rodent%20hepatocytes&rft.jtitle=Innate%20immunity%20(London,%20England)&rft.au=Bartolome,%20N&rft.date=2008-08-01&rft.volume=14&rft.issue=4&rft.spage=255&rft.epage=266&rft.pages=255-266&rft.issn=1753-4259&rft_id=info:doi/10.1177/1753425908094718&rft_dat=%3Cproquest%3E20210402%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20210402&rft_id=info:pmid/&rfr_iscdi=true